Monthly dapagliflozin therapy improves the nanomechanical properties of red blood cells in patients with type 1 diabetes

Background and Purpose Sodium-glucose cotransporter 2 (SGLT2) selective inhibitors (flozins) are a class of antidiabetic drugs that improve glycemic control and have significant cardioprotective effects. The purpose of investigating flozins as adjunct